TranS1 Empowers Surgeons

We believe that empowering surgeons leads to breakthrough innovations. TranS1 offers a full suite of research and development capabilities to support surgeons to build concepts into market viable technologies. Our product development resources are built to surgeon specifications and can be activated to support finite projects or to manage the entire development process.

Research and Development Process

Roll over for more information

Surgeon-activated research and development with an experienced team of engineers

R&D team with an extensive track record of breakthroughs, particularly in minimally invasive spine

We provide the agility to rapidly define, develop, protect, and bring innovations to market

Interested in learning more about the R&D process and how TranS1 can help make your vision a reality?

TranS1 coming back to Port City

May 15, 2018
WILMINGTON -- A maker of spinal surgery devices that left Wilmington several years ago is returning to the Port City, one of its executives said.
Read More

TranS1® Announces Three New Patents

February 13, 2018
Spinal device company expands portfolio of innovative devices with a goal of improving patient outcomes and reducing hospital stays Denver,...
Read More

Always ahead of the curve, AxiaLIF+ has been expandable since its inception. With AxiaLIF+ distraction can be dialed in to suit the patient/pathology. AxiaLIF+ must be used with supplemental fixation. Please see Indications For Use. #buildingbetterpathways #AxiaLIF2019

Happy 4th from the team at TranS1! #redwhiteandblue #starsandstripes

"Improving a patient's quality of life keeps me passionate about the work that I do and makes me strive to constantly develop as an engineer." #tuesdayteammember #T14life #buildingbetterpathways - Learn more about AxiaLIF and request training #AxiaLIF #spinefusion #lumbarspinesurgery #minimallyinvasivespinesurgery

"I am proud of our commitment to bringing new innovative products to market while always focusing on regulatory compliance. I enjoy working with regulatory agencies to bring new safe and effective options to patients." #tuesdayteammember #T14life #buildingbetterpathways

Load More...